Evidence map›Paper›PMID 28480224›Full record

ArticleInternational journal of food science, nutrition and dietetics2015

Safety, Feasibility, and Biomarker Effects of High-Dose Vitamin D Supplementation Among Women at High Risk for Breast Cancer.

K D Crew, T Xiao, P S Thomas, M B Terry, M Maurer, K Kalinsky, S Feldman, L Brafman, S R Refice, D L Hershman

Open access · diamondAbstract read
In one paragraph

Article in International journal of food science, nutrition and dietetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Reassessing the Association between Circulating Vitamin D and IGFBP-3: Observational and Mendelian Randomization Estimates from Independent Sources.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

K D CrewDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
T XiaoDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
P S ThomasDepartment of Clinical Cancer Prevention, MD Anderson Cancer Center, Houston, TX, USA.
M B TerryDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
M MaurerDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
K KalinskyDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
S FeldmanHerbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.
L BrafmanHerbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.
S R ReficeHerbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.
D L HershmanDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Columbia University Irving Medical Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024156 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2006 to 2011
$53.0M
NCRR NIH HHS UL1 RR024156
6 · The paper itself

Abstract

Vitamin D deficiency is a potentially modifiable risk factor that may be targeted for breast cancer prevention. We examined the safety, feasibility, and biomarker effects of high-dose vitamin D among women at high risk for breast cancer. Forty high-risk women, defined as a 5-year breast cancer risk ≥1.67% per the Gail model, lobular or ductal carcinoma

Indexed as

BiomarkersBreast CancerChemopreventionVitamin D

Identifiers

PMID28480224
PMCPMC5415303
OpenAlexW2803262643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.